Accession Number: | 0001562180-22-004878 |
Date: | 2022-06-03 |
Issuer: | REGENXBIO INC. (RGNX) |
Original Submission Date: |
KARABELAS ARGERIS N
C/O REGENXBIO INC.
9804 MEDICAL CENTER DRIVE
ROCKVILLE, MD 20850
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2022-06-03 | A | 3,010 | a | $0.00 | 3,010 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 22.84 | 2022-06-03 | deemed execution date | A | 15,324 (a) | 2032-06-03 | common stock 15,324 | $22.84 | 15,324 | direct |
ID | footnote |
---|---|
f1 | represents shares of common stock underlying a time-based restricted stock unit award (rsu). 100% of the shares subject to this rsu will vest on june 1, 2023 while the recipient provides continuous service to the issuer. |
f2 | the option will vest in 12 equal monthly installments following june 3, 2022 while the optionee provides continuous service to the issuer. |